Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | CES2 | O00748 | 4/20 | 0.62 |
| ▸ | CES1 | P23141 | 4/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | PPARG | P37231 | 7/20 | 0.59 |
| ▸ | PPARD | Q03181 | 7/20 | 0.59 |
| ▸ | PPARA | Q07869 | 7/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TLR2 | O60603 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.59 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3308042 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL3051705 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL11672548 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL11673566 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL11673555 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL7760601 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL23437862 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL11673647 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL15941224 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 | |
| SCHEMBL7757516 | 1.00 | HAO1 (0.71) | HAO1KMT2AMAPTCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114729100-B | Blocked polyisocyanate crosslinking agent, process for producing the same and coating composition comprising the same | 巴斯夫涂料有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-114288422-B | Liposome for degrading target protein in chemical targeting manner and preparation method thereof | 陕西科技大学 | 2023-04-28 | — | — | CN | claimed |
| CN-112773766-B | Liposome delivery system for tumor treatment and preparation method and application thereof | 暨南大学 | 2022-10-18 | — | — | CN | claimed |
| CN-114729100-A | Blocked polyisocyanate crosslinkers, process for their preparation and coating compositions comprising the crosslinkers | 巴斯夫涂料有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114288422-A | Liposome for chemically targeted degradation of target protein and preparation method thereof | 陕西科技大学 | 2022-04-08 | — | — | CN | claimed |
| US-11260068-B2 | Long-circulating liposome modified with c(RGD-ACP-K) | BEIJING GREATSUN BTO-PHARM. TECH. CO., LTD (CN) | 2022-03-01 | — | — | US | claimed |
| CN-113975244-A | Bionic magnetic targeting cationic liposome and preparation method and application thereof | 上海交通大学医学院附属第九人民医院 | 2022-01-28 | — | — | CN | claimed |
| CN-112773766-A | Liposome delivery system for tumor treatment and preparation method and application thereof | 暨南大学 | 2021-05-11 | — | — | CN | claimed |
| WO-2020257260-A1 | FORMULATION OF PEPTIDE LOADED LIPOSOMES AND RELATED APPLICATIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-12-24 | — | — | WO | claimed |
| CN-108926719-B | Long-circulating liposomes modified with c (RGD-ACP-K) | 北京格瑞特森生物医药科技有限公司 | 2020-09-01 | — | — | CN | claimed |
| US-20200197424-A1 | LONG-CIRCULATING LIPOSOME MODIFIED WITH C(RGD-ACP-K) | BEIJING GREATSUN BIO-PHARM. TECH. CO., LTD (CN) | 2020-06-25 | — | — | US | claimed |
| EP-3632413-A1 | LONG-CIRCULATING LIPOSOME MODIFIED WITH C(RGD-ACP-K) | Beijing Greatsun Bio-pharm. Tech. Co., Ltd (CN) | 2020-04-08 | — | — | EP | claimed |
| US-20240327291-A1 | MULTIVALENT MANGANESE OXIDE FILLER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | UNIV CHONGQING (CN) | 2024-10-03 | — | — | US | disclosed |
| CN-114729100-B | Blocked polyisocyanate crosslinking agent, process for producing the same and coating composition comprising the same | 巴斯夫涂料有限公司 | 2024-04-16 | — | — | CN | disclosed |
| EP-3473256-B1 | INTRATUMORAL VEIN FORMATION PROMOTER | UNIV OSAKA (JP) | 2023-12-06 | — | — | EP | disclosed |
| CN-117100644-A | Semitransparent to transparent aqueous solution containing sphingosine and non-salt derivatives and preparation method thereof | 中妆美科(合肥)新材料技术有限公司 | 2023-11-24 | — | — | CN | disclosed |
| WO-2018052835-A1 | COMPOSITIONS COMPRISING ANTISENSE-ENCODED ERYTHROPOIETIN RECEPTOR AND USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-03-22 | — | — | WO | disclosed |
| WO-2015021465-A2 | PROTEIN ENGINEERED SYSTEMS FOR DELIVERY OF MOLECULES | NEW YORK UNIVERSITY (US) | 2015-02-12 | — | — | WO | disclosed |
| EP-2516010-A2 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | Novartis AG (CH) | 2012-10-31 | — | — | EP | disclosed |
| WO-2011076807-A2 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | NOVARTIS AG (CH) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200197424-A1 | LONG-CIRCULATING LIPOSOME MODIFIED WITH C(RGD-ACP-K) | VEGFA, DCK, ACP1 | HAO1 4243/4885KMT2A 2397/4885MAPT 4073/4885 |
| US-11260068-B2 | Long-circulating liposome modified with c(RGD-ACP-K) | VEGFA, DCK, ACP1 | HAO1 4243/4885KMT2A 2397/4885MAPT 4073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.